INTERNATIONAL PATENT: PFIZER INC. FILES APPLICATION FOR "METHOD OF FORMING MULTI-SPECIFIC ANTIBODIES FROM HOMODIMER ANTIBODIES AND PHARMACEUTICAL PRODUCT INCLUDING MULTI-SPECIFIC ANTIBODIES THUS OBTAINED"

GENEVA, May 5 -- PFIZER INC. (66 Hudson Boulevard EastNew York, New York 10001-2192) filed a patent application (PCT/IB2024/060432) for "METHOD OF FORMING MULTI-SPECIFIC ANTIBODIES FROM HOMODIMER ANTIBODIES AND PHARMACEUTICAL PRODUCT INCLUDING MULTI-SPECIFIC ANTIBODIES THUS OBTAINED" on Oct 23, 2024. With publication no. WO/2025/088516, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE, Arnab (c/o Pfizer Inc.1 Burtt RoadAndover, Massachusetts 01810), ERIKSEN-STAPLETON, Dawn (c/o Pfizer Inc.1 Burtt RoadAndover, Massachuse...